125 Views

VC-backed security data provider Rapid7 goes public

Security data and analytics provider Rapid7 has debuted its IPO after pricing its 6.45 million shares at $16 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “RPD.” Morgan Stanley & Co. LLC and Barclays Capital Inc are serving as the lead underwriters. Rapid7 is backed by Bain Capital and Technology Crossover Ventures.

PE-backed UTAC Holdings files for IPO

Singapore-based UTAC Holdings Ltd, a provider of test, assembly and full turnkey services for a wide range of semiconductor devices, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. The company plans on listing the stock on either the New York Stock Exchange or NASDAQ. UTAC’s backers include Affinity Equity Partners and TPG Capital.

119 Views

VC-backed Teladoc debuts IPO

Telehealth platform Teladoc has raised $156.75 million for its IPO after pricing its 8.25 million shares (originally planned at 7 million) at $19 per share. The stock began trading Wednesday on the New York Stock Exchange under the ticker symbol “TDOC.” J.P. Morgan Securities LLC and Deutsche Bank Securities Inc are the lead underwriters. Teladoc’s backers include Icon Ventures, FLAG Capital Management, Greenspring Associates, QuestMark Partners, Cardinal Partners, HLM Venture Partners, Kleiner Perkins Caufield & Byers, New Capital Partners and Trident Capital.

162 Views

PE-backed extreme value retailer Ollie’s files for IPO

Harrisburg, Pennsylvania-based extreme value retailer Ollie’s Bargain Outlet Holdings Inc has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. J.P. Morgan, Jefferies and BofA Merrill Lynch are the lead underwriters. Ollie’s is a portfolio company of CCMP Capital.

143 Views

VC-backed ProNAi files for IPO

Vancouver-based ProNAi Therapeutics, a developer of nucleic acid therapeutics, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. The stock will list on the NASDAQ under the ticker symbol “DNAI.” Jefferies LLC and BofA Merrill Lynch will serve as the lead underwriters. ProNAi’s backers include Vivo Capital, Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life Science Ventures, Sectoral Asset Management and Janus Capital Management.

174 Views

PE-backed Patheon files for IPO

Durham, North Carolina-based Patheon, a provider of outsourced pharmaceutical development and manufacturing services, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. J.P. Morgan, Morgan Stanley, Jefferies and UBS are serving as the lead underwriters. Patheon is owned by JLL Partners and Royal DSM.

PE HUB Community

Join the 12519 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget